Elsevier,
Treatment of Skin Disease (Fifth Edition)
Comprehensive Therapeutic Strategies
2018, Pages 621-623
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing content on Peutz–Jeghers syndrome (PJS), a rare hereditary disorder of polyposis.
Elsevier,
Treatment of Skin Disease (Fifth Edition)
Comprehensive Therapeutic Strategies
2018, Pages 764-768
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on scleroderma, a rare multisystem disease characterized by skin fibrosis, autoantibody production, and vascular abnormalities often leading to visceral disease.
Elsevier,
Epigenetics of Stress and Stress Disorders, Volume 31 in Translational Epigenetics, 2022, Pages 137-162
Reviews the literature on the epigenetics of PTSD and interpret findings through the lens of understanding the implications for adverse physical health outcomes. The goal of SDG target is to cover treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders.
This chapter aligns with the SDG goal 3 of good health and wellbeing by summarizing hepatic diseases and inflammation and strategies to treat them.
Diabetic neuropathy is the most debilitating complication that can cause significant morbidity and mortality in type 1 and type 2 diabetic patients. It is essential to detect symptoms or signs of diabetic neuropathy and determine risk factors as early as possible to implement interventions and to prevent further neuronal damage. The goal of SDG 3.4 is to reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being 3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
The relationship between healthy lifestyles and wellbeing, especially focused on women and pregnancy, continues to grow to understand and determine factors connected to chronic disease and to decrease them. Supports SDG target: 3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births
Elsevier,
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 1 - Biology and Pathophysiology, 2022, Pages 257-285
This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the current view of the pathogenesis of HBV and HCV along with the report on their relation to the genotypes.
The sampling of interstitial fluid for real-time assay requires techniques that are sensitive, rapid, painless, minimally invasive and easy to use by patients. Microneedles can be incorporated into biosensors with subsequent use of these platforms for continuous monitoring or bio-chemical detection of analytes in the dermal interstitial fluid. Supports the goal of SDG 3.8 to achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.
Elsevier,
Diabetes Without Needles, Non-invasive Diagnostics and Health Management, 2022, Pages 27-92
Introduces diabetes including past, present, and future achievements in this field. The goal of SDG target 3.4.1 is to reduce the mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
Elsevier,
The COVID-19 Response: The Vital Role of the Public Health Professional, 2023, Pages 143-154
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by examining the role of social determinants and racism in COVID's inequitable impacts, the burnout of the workforce, and the politicization of the response as major factors that will influence the future of the public health system.
